Status:
COMPLETED
Lung Health Study II
Lead Sponsor:
University of Minnesota
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Lung Diseases
Lung Diseases, Obstructive
Eligibility:
All Genders
40-69 years
Phase:
PHASE3
Brief Summary
To determine if participants with chronic obstructive pulmonary disease, who were assigned to inhaled corticosteroids had a lower rate of decline in lung function and lower incidence of respiratory mo...
Detailed Description
BACKGROUND: Chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the United States and a major cause of morbidity, is a spectrum of chronic lung diseases including clini...
Eligibility Criteria
Inclusion:
- Previously participated in or screened for the Lung Health Study I
- Ages 40 to 69
- Forced expiratory volume at one second (FEV1)/forced vital capacity(FVC) < 70 percent
- Forced expiratory volume at one second (FEV1) 30 to 90 percent predicted.
Exclusions:
- Cancer
- Recent myocardial infarction
- Alcoholism
- Heart Failure
- Insulin-dependent diabetes mellitus
- Neuropsychiatric disorders
- Used bronchodilators or oral or inhaled corticosteroids in previous year
Key Trial Info
Start Date :
September 1 1993
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 1999
Estimated Enrollment :
1116 Patients enrolled
Trial Details
Trial ID
NCT00000569
Start Date
September 1 1993
End Date
May 1 1999
Last Update
November 1 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.